Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2020-03-27 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
第六届监事会第六次临时会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement from the supervisory board of 嘉事堂药业股份有限公司 regarding resolutions passed in a supervisory board meeting. It details changes in senior management positions, specifically the change of the company president and a supervisory board member. The document includes voting results and references to compliance with company law and internal rules. It does not contain financial statements, audit information, or detailed financial analysis. It is not a report or presentation but an official announcement of management changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on management changes, confirming this classification.
2020-03-27 Chinese
第六届董事会第六次临时会议决议公告
Board/Management Information Classification · 100% confidence The document is an announcement of a board meeting resolution regarding a change in the company's president. It details the decision made by the board, voting results, and references related announcements. There is no financial data, audit information, or report content. The focus is on management change, specifically the appointment of the chairman as president and the resignation of the previous president. This fits the category of Board/Management Information (MANG). The document length is short and it is not a report or financial statement, but a formal announcement of management change.
2020-03-27 Chinese
关于变更公司总裁的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding a change in the company's president (总裁). It details the resignation of the previous president and the appointment of the chairman as the new president, including biographical information and compliance statements. There are no financial statements, earnings data, or regulatory filings related to financial performance. The content focuses on management changes at the senior executive level. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not a report or announcement of a report publication, so it is not RPA or RNS.
2020-03-27 Chinese
关于变更监事的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding a change in the company's supervisory board member (监事). It details the resignation of one supervisor and the nomination of a new candidate, including the candidate's resume and compliance with relevant laws and regulations. There is no financial data, no mention of financial results, no report publication, or regulatory certification. The content clearly fits the category of Board/Management Information, specifically about changes in the company's supervisory board members, which falls under the 'MANG' classification.
2020-03-27 Chinese
独立董事关于公司第六届董事会第六次临时会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from the independent directors of a company regarding a specific board meeting item, namely the proposal to change the company's president. It references compliance with company law, governance codes, and company articles, and confirms the legality and appropriateness of the nomination. The document is short (671 characters) and does not contain financial data or detailed management discussion. It is focused on board/management matters, specifically a management change proposal. Therefore, it fits best under the category of Board/Management Information (MANG).
2020-03-27 Chinese
第六届监事会第五次临时会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement of a resolution passed by the supervisory board (监事会) of 嘉事堂药业股份有限公司 regarding the temporary use of idle raised funds to supplement working capital. It includes details of the meeting date, voting results, and references a prior public announcement of the related funding use. The document is short (749 characters) and serves as a disclosure of a board decision rather than a full financial report or detailed management discussion. It does not contain financial statements or detailed financial data. It is an announcement related to capital use and financing activities, specifically about the use of raised funds. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-03-13 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.